Billiontoone, Inc. (NASDAQ:BLLN) Stock Rated "Hold" by Wall Street Brokerages

Key Points

• Analysts have a consensus “Hold” rating on Billiontoone, with seven buys, two holds and two sells. The average 12-month price target is $125.88, while several firms recently lowered their targets to about $130.
• Company insiders sold heavily: executives sold 241,576 shares worth approximately $27.7 million over the past 90 days, including substantial sales by the CEO and CTO under pre-arranged trading plans.
• Billiontoone reported quarterly EPS of $0.15, in line with estimates, on revenue of $109.45 million. The stock opened at $123.08, with a $5.81 billion market capitalization and a notably high P/E ratio of 175.83.

Shares of Billiontoone, Inc. (NASDAQ:BLLN - Get Free Report) have received a consensus rating of "Hold" from the eleven ratings firms that are currently covering the stock, MarketBeat.com reports. Two analysts have rated the stock with a sell recommendation, two have issued a hold recommendation and seven have issued a buy recommendation on the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $125.88.

BLLN has been the subject of a number of research reports. Wall Street Zen cut Billiontoone from a "buy" rating to a "hold" rating in a research note on Saturday, August 8th. BTIG Research lowered their target price on shares of Billiontoone from $142.00 to $130.00 and set a "buy" rating on the stock in a research report on Thursday, August 6th. Guggenheim initiated coverage on shares of Billiontoone in a report on Monday, June 29th. They issued a "buy" rating and a $125.00 target price on the stock. Weiss Ratings reiterated a "sell (d+)" rating on shares of Billiontoone in a research report on Friday, September 18th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Billiontoone from $145.00 to $130.00 and set an "overweight" rating for the company in a research note on Thursday, August 6th.

Insider Buying and Selling at Billiontoone

In other news, CEO Oguzhan Atay sold 24,999 shares of the company's stock in a transaction dated Monday, September 14th. The shares were sold at an average price of $100.32, for a total value of $2,507,899.68. Following the completion of the sale, the chief executive officer directly owned 16,666 shares of the company's stock, valued at approximately $1,671,933.12. This represents a 60.00% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CTO David Tsao sold 20,000 shares of the stock in a transaction dated Wednesday, September 9th. The stock was sold at an average price of $98.77, for a total transaction of $1,975,400.00. Following the sale, the chief technology officer owned 1,000 shares of the company's stock, valued at $98,770. This trade represents a 95.24% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 241,576 shares of company stock valued at $27,675,002 over the last ninety days. 50.22% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently modified their holdings of BLLN. Integrated Wealth Concepts LLC purchased a new stake in shares of Billiontoone during the second quarter worth approximately $29,000. MCF Advisors LLC grew its position in Billiontoone by 330.8% in the 2nd quarter. MCF Advisors LLC now owns 448 shares of the company's stock valued at $54,000 after buying an additional 344 shares during the last quarter. Caitong International Asset Management Co. Ltd purchased a new position in Billiontoone in the 4th quarter valued at $230,000. Thrive Wealth Management LLC acquired a new position in Billiontoone in the 2nd quarter valued at $240,000. Finally, Jasper Ridge Partners L.P. acquired a new position in Billiontoone in the 2nd quarter valued at $615,000.

Billiontoone Stock Down 1.5%

BLLN opened at $123.08 on Friday. Billiontoone has a one year low of $61.96 and a one year high of $150.44. The company has a debt-to-equity ratio of 0.17, a quick ratio of 11.31 and a current ratio of 11.69. The stock has a market capitalization of $5.81 billion and a P/E ratio of 175.83. The business's 50-day simple moving average is $108.73 and its 200-day simple moving average is $98.32.

Billiontoone (NASDAQ:BLLN - Get Free Report) last announced its earnings results on Wednesday, August 5th. The company reported $0.15 earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of $0.15. The firm had revenue of $109.45 million during the quarter. Billiontoone had a return on equity of 9.96% and a net margin of 8.04%. Analysts anticipate that Billiontoone will post 0.83 EPS for the current year.

About Billiontoone

BillionToOne, Inc is a molecular diagnostics company that develops blood-based tests designed to provide genetic and health information from small amounts of biological material. The company's technology uses its proprietary quantitative counting template approach to improve the accuracy and sensitivity of molecular testing.

The company's primary offerings include UNITY, a portfolio of prenatal genetic tests. These services support screening for chromosomal conditions, single-gene disorders and carrier status, and are designed to help healthcare providers assess fetal and maternal genetic risks using a maternal blood sample.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.